ADAM Proteases in Physiology and Pathophysiology: Cleave to Function in Health or to Cause Disease

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-3-7091-0885-7_9
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Oncogenic Kras promotes chemotherapy-induced growth factor shedding via ADAM17.

  2011cited by this paper
• ADAM17 (TACE) regulates TGFβ signaling through the cleavage of vasorin

  2011cited by this paper
• CRP enhances soluble LOX-1 release from macrophages by activating TNF-α converting enzyme

  2011cited by this paper
• Cross-domain inhibition of TACE ectodomain

  2011cited by this paper
• ADAM17: a molecular switch to control inflammation and tissue regeneration.

  2011cited by this paper
• Soluble M6P/IGF2R Released by TACE Controls Angiogenesis via Blocking Plasminogen Activation

  2011cited by this paper
• A transforming Src mutant increases the bioavailability of EGFR ligands via stimulation of the cell-surface metalloproteinase ADAM17

  2011cited by this paper
• Deciphering the human platelet sheddome.

  2011cited by this paper
• Chemotherapy-Induced Activation of ADAM-17: A Novel Mechanism of Drug Resistance in Colorectal Cancer

  2010cited by this paper
• ADAM-17: the enzyme that does it all

  2010cited by this paper
• Lymphotoxin-alphabeta heterotrimers are cleaved by metalloproteinases and contribute to synovitis in rheumatoid arthritis.

  2010cited by this paper
• MyD88 signaling in nonhematopoietic cells protects mice against induced colitis by regulating specific EGF receptor ligands

  2010cited by this paper
• In vivo role of leukocyte ADAM17 in the inflammatory and host responses during E. coli‐mediated peritonitis

  2010cited by this paper
• Pathological Neovascularization Is Reduced by Inactivation of ADAM17 in Endothelial Cells but Not in Pericytes

  2010cited by this paper
• Ectodomain shedding of EGFR ligands and TNFR1 dictates hepatocyte apoptosis during fulminant hepatitis in mice.

  2010cited by this paper
• HER2 Phosphorylation Is Maintained by a PKB Negative Feedback Loop in Response to Anti-HER2 Herceptin in Breast Cancer

  2010cited by this paper
• Tumor necrosis factor -converting enzyme (TACE/ADAM17) mediates ectodomain shedding of the scavenger receptor CD163

  2010cited by this paper
• Ectodomain shedding of the Notch ligand Jagged1 is mediated by ADAM17, but is not a lipid-raft-associated event.

  2010cited by this paper
• Thiol isomerases negatively regulate the cellular shedding activity of ADAM17.

  2010cited by this paper
• Critical role of the disintegrin metalloprotease ADAM17 for intestinal inflammation and regeneration in mice

  2010cited by this paper
• ADAM17 regulates epidermal growth factor receptor expression through the activation of Notch1 in non-small cell lung cancer.

  2010cited by this paper
• Ectodomain shedding of Fcα receptor is mediated by ADAM10 and ADAM17

  2010cited by this paper
• Differentially regulated GPVI ectodomain shedding by multiple platelet-expressed proteinases.

  2010cited by this paper
• Regulated release and functional modulation of junctional adhesion molecule A by disintegrin metalloproteinases.

  2009cited by this paper
• Structures of two elapid snake venom metalloproteases with distinct activities highlight the disulfide patterns in the D domain of ADAMalysin family proteins

  2009cited by this paper
• Ectodomain Shedding of FLT3 Ligand Is Mediated by TNF-α Converting Enzyme1

  2009cited by this paper
• A Disintegrin and Metalloproteinase 17 (ADAM17) Mediates Inflammation-induced Shedding of Syndecan-1 and -4 by Lung Epithelial Cells*

  2009cited by this paper
• ADAM17 as a therapeutic target in multiple diseases.

  2009cited by this paper
• Conditional Inactivation of TACE by a Sox9 Promoter Leads to Osteoporosis and Increased Granulopoiesis via Dysregulation of IL-17 and G-CSF1

  2009cited by this paper
• Nuclear signalling by tumour-associated antigen EpCAM

  2009cited by this paper
• Cutting Edge: The Metalloproteinase ADAM17/TNF-α-Converting Enzyme Regulates Proteolytic Shedding of the MHC Class I-Related Chain B Protein1

  2009cited by this paper
• Formation of Pmel17 Amyloid Is Regulated by Juxtamembrane Metalloproteinase Cleavage, and the Resulting C-terminal Fragment Is a Substrate for γ-Secretase*

  2009cited by this paper
• Insulin-degrading enzyme is exported via an unconventional protein secretion pathway

  2009cited by this paper
• Regulation of Mature ADAM17 by Redox Agents for L-Selectin Shedding1

  2009cited by this paper
• TNFalpha shedding and epidermal inflammation are controlled by Jun proteins.

  2009cited by this paper
• LRP1 shedding in human brain: roles of ADAM10 and ADAM17

  2009cited by this paper
• ADAMs 10 and 17 represent differentially regulated components of a general shedding machinery for membrane proteins such as transforming growth factor alpha, L-selectin, and tumor necrosis factor alpha.

  2009cited by this paper
• Structural determinants of the ADAM inhibition by TIMP-3: crystal structure of the TACE-N-TIMP-3 complex.

  2008cited by this paper
• Drug Insight: tumor necrosis factor-converting enzyme as a pharmaceutical target for rheumatoid arthritis

  2008cited by this paper
• VEGF-A Stimulates ADAM17-Dependent Shedding of VEGFR2 and Crosstalk Between VEGFR2 and ERK Signaling

  2008cited by this paper
• Clipping, shedding and RIPping keep immunity on cue.

  2008cited by this paper
• Multiple Mechanisms Are Responsible for Transactivation of the Epidermal Growth Factor Receptor in Mammary Epithelial Cells*

  2008cited by this paper
• The ADAM metalloproteinases

  2008cited by this paper
• Deficiency of TNFalpha converting enzyme (TACE/ADAM17) causes a lean, hypermetabolic phenotype in mice.

  2008cited by this paper
• The ADAMs: signalling scissors in the tumour microenvironment

  2008cited by this paper
• Metalloproteinase- and γ-Secretase-mediated Cleavage of Protein-tyrosine Phosphatase Receptor Type Z*

  2008cited by this paper
• Role of ADAM17 in the ectodomain shedding of TNF‐α and its receptors by neutrophils and macrophages

  2007cited by this paper
• Non-Cell Autonomous Expression of TNF-α-Converting Enzyme ADAM17 Is Required for Normal Lymphocyte Development1

  2007cited by this paper
• Targeting TACE-dependent EGFR ligand shedding in breast cancer.

  2007cited by this paper
• The ADAM10 Prodomain Is a Specific Inhibitor of ADAM10 Proteolytic Activity and Inhibits Cellular Shedding Events*

  2007cited by this paper
• Phorbol Ester-induced Shedding of the Prostate Cancer Marker Transmembrane Protein with Epidermal Growth Factor and Two Follistatin Motifs 2 Is Mediated by the Disintegrin and Metalloproteinase-17*

  2007cited by this paper
• The TACE zymogen

  2007cited by this paper
• Cutting Edge: TNF-α-Converting Enzyme (TACE/ADAM17) Inactivation in Mouse Myeloid Cells Prevents Lethality from Endotoxin Shock1

  2007cited by this paper
• Crystal structures of VAP1 reveal ADAMs' MDC domain architecture and its unique C‐shaped scaffold

  2006cited by this paper
• ADAM17 deficiency by mature neutrophils has differential effects on L-selectin shedding.

  2006cited by this paper
• ADAM10 cleavage of N‐cadherin and regulation of cell–cell adhesion and β‐catenin nuclear signalling

  2005cited by this paper
• Adam meets Eph: an ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans.

  2005cited by this paper
• Evidence for a Role of ADAM17 (TACE) in the Regulation of Platelet Glycoprotein V*

  2005cited by this paper
• ADAMs: key components in EGFR signalling and development

  2005cited by this paper
• ADAM10 Mediates Ectodomain Shedding of the Betacellulin Precursor Activated by p-Aminophenylmercuric Acetate and Extracellular Calcium Influx*

  2005cited by this paper
• Design of effective immunotherapy for human autoimmunity

  2005cited by this paper
• ERK-mediated phosphorylation of Thr735 in TNFα-converting enzyme and its potential role in TACE protein trafficking

  2005cited by this paper
• Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands

  2004cited by this paper
• Cell–matrix interaction via CD44 is independently regulated by different metalloproteinases activated in response to extracellular Ca2+ influx and PKC activation

  2004cited by this paper
• Tumor Necrosis Factor- (cid:1) –Converting Enzyme (ADAM17) Mediates GPIb (cid:1) Shedding From Platelets In Vitro and In Vivo

  2004cited by this paper
• Characterization of Growth Factor-induced Serine Phosphorylation of Tumor Necrosis Factor-α Converting Enzyme and of an Alternatively Translated Polypeptide*

  2003cited by this paper
• TACE/ADAM-17 enzymatic activity is increased in response to cellular stimulation.

  2003cited by this paper
• Cellular Cholesterol Depletion Triggers Shedding of the Human Interleukin-6 Receptor by ADAM10 and ADAM17 (TACE)*

  2003cited by this paper
• Extracellular signal-regulated kinase phosphorylates tumor necrosis factor alpha-converting enzyme at threonine 735: a potential role in regulated shedding.

  2002cited by this paper
• Recognition sequences and structural elements contribute to shedding susceptibility of membrane proteins.

  2001cited by this paper
• Functional Analysis of the Domain Structure of Tumor Necrosis Factor-α Converting Enzyme*

  2000cited by this paper
• The in vitro activity of ADAM‐10 is inhibited by TIMP‐1 and TIMP‐3

  2000cited by this paper
• Evidence for a Role of a Tumor Necrosis Factor-α (TNF-α)-converting Enzyme-like Protease in Shedding of TRANCE, a TNF Family Member Involved in Osteoclastogenesis and Dendritic Cell Survival*

  1999cited by this paper
• C-reactive Protein: A Physiological Activator of Interleukin 6 Receptor Shedding

  1999cited by this paper
• An essential role for ectodomain shedding in mammalian development.

  1998cited by this paper
• TNF‐α converting enzyme (TACE) is inhibited by TIMP‐3

  1998cited by this paper
• Pore-forming toxins trigger shedding of receptors for interleukin 6 and lipopolysaccharide.

  1996cited by this paper
• Structural features of a superfamily of zinc-endopeptidases: the metzincins.

  1995cited by this paper

• Meprin and ADAM proteases as triggers of systemic inflammation in sepsis

  2021cites this paper
• Cancer – Proteases in the Progression and Metastasis

  2016cites this paper
• Proteolysis mediated by cysteine cathepsins and legumain—recent advances and cell biological challenges

  2015cites this paper
• Mechanisms of proteolytic activity regulation exerted via a unique propeptide in matrix metalloproteinases and intra/intermolecular interactions in a novel family of minimal gluzincins

  2015cites this paper